Listly by integral bioscience
The CRO offers the full range of integrated drug discovery services including medicinal chemistry research and biology studies.
Developing a new therapeutic requires the perfect balance between chemistry and biology studies. Medicinal chemistry research plays a pivotal role during early drug discovery.
Chemists can set the right course for a drug discovery project with their expertise. Drug discovery chemistry services are required to assess critical factors such as assessing in vivo compound stability, solubility, and others.
Medicinal chemistry research during the early stages helps in identifying promising compounds that can be transformed into marketable drugs.
Developing a new therapeutic requires the perfect balance between chemistry and biology studies. Medicinal chemistry research plays a pivotal role during early drug discovery.
Established in 2008, Integral Biosciences Pvt. Ltd (IBS) is a drug discovery service provider or incubator, which offers end-to-end integrated drug discovery services to innovation-focused biotech start-ups and small to mid-sized pharmaceutical companies. IBS is a well renowned Contract Research Organisation (CRO) in India providing preclinical development solution.
Medicinal chemistry is a dynamic field of biosciences that links many scientific disciplines and enables collaboration with other scientists in drug discovery services. Chemistry Research Services is a crucial part of drug discovery laboratories working on the research and development of new drugs.
Medicinal chemists have always played a crucial role in the pharmaceutical industry and medicinal chemistry research is still one major driver in the drug discovery processes. Medicinal chemistry research deals with pharmacoanalysis and the chemical analysis of compounds in the form of small organic molecules.
Drug designing involves numerous fields of biosciences and medicinal chemistry research play a significant role in it. Since medicinal chemists leverage their knowledge of organic chemistry, the biology of the disease, in vitro and in vivo pharmacological screening, and pharmacokinetic characteristics, thus they have become an inevitable part of drug designing.
The growth of the drug discovery industry has been significant in recent years. It is expected to attain the level of USD 19 billion by 2025 from USD 10.7 billion in 2020, at a CAGR of 12.1%. Growing R&D expenditure, increasing demand for outsourcing analytical services and various drug discovery chemistry services, together are pushing the drug discovery industry ahead.
Medicinal chemistry services are an important part of drug discovery services. It deals with design, development, synthesis and ADME services for drug discovery.
Preclinical development includes drug discovery activities in the laboratory to initiate human clinical trials. In that stage, CROs often use computer aided drug designing methods to speed up the processes with accuracy. They utilise CADD tools to determine the absorption, distribution, metabolism, and excretion properties of the corresponding drug candidates.